BRPI0920069A2 - biomarcadores - Google Patents
biomarcadoresInfo
- Publication number
- BRPI0920069A2 BRPI0920069A2 BRPI0920069A BRPI0920069A BRPI0920069A2 BR PI0920069 A2 BRPI0920069 A2 BR PI0920069A2 BR PI0920069 A BRPI0920069 A BR PI0920069A BR PI0920069 A BRPI0920069 A BR PI0920069A BR PI0920069 A2 BRPI0920069 A2 BR PI0920069A2
- Authority
- BR
- Brazil
- Prior art keywords
- biomarkers
- Prior art date
Links
- 239000000090 biomarker Substances 0.000 title 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
- G16Z99/00—Subject matter not provided for in other main groups of this subclass
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/325—Heart failure or cardiac arrest, e.g. cardiomyopathy, congestive heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Pathology (AREA)
- Primary Health Care (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10964908P | 2008-10-30 | 2008-10-30 | |
| PCT/EP2009/064410 WO2010049538A1 (en) | 2008-10-30 | 2009-10-30 | Biomarkers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0920069A2 true BRPI0920069A2 (pt) | 2017-06-06 |
| BRPI0920069A8 BRPI0920069A8 (pt) | 2017-10-03 |
Family
ID=41528764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0920069A BRPI0920069A8 (pt) | 2008-10-30 | 2009-10-30 | Biomarcadores |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20110294683A1 (pt) |
| EP (1) | EP2362942B1 (pt) |
| JP (1) | JP5749171B2 (pt) |
| CN (1) | CN102203606A (pt) |
| BR (1) | BRPI0920069A8 (pt) |
| CA (1) | CA2741117A1 (pt) |
| ES (1) | ES2640900T3 (pt) |
| RU (1) | RU2545757C2 (pt) |
| WO (1) | WO2010049538A1 (pt) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5905003B2 (ja) | 2010-07-09 | 2016-04-20 | ソマロジック・インコーポレーテッド | 肺癌バイオマーカーとその使用 |
| MX350533B (es) | 2010-08-13 | 2017-09-08 | Somalogic Inc | Biomarcadores de cancer pancreatico y usos de los mismos. |
| EP2592423A1 (en) | 2011-11-08 | 2013-05-15 | Zora Biosciences OY | Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment |
| EP2592422A1 (en) | 2011-11-08 | 2013-05-15 | Zora Biosciences OY | Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment |
| JP2014207883A (ja) * | 2013-03-27 | 2014-11-06 | 国立大学法人岡山大学 | がん幹細胞及びその用途 |
| EP3511014A1 (en) * | 2013-05-31 | 2019-07-17 | CoBioRes NV | Human plgf-2 for the prevention or treatment of heart failure resulting from chronic myocardial ischemia |
| EP2843414B1 (en) | 2013-08-26 | 2018-09-19 | Roche Diagniostics GmbH | Marker for statin treatment stratification in heart failure |
| CN103487586B (zh) * | 2013-09-04 | 2015-07-15 | 石家庄洹众生物科技有限公司 | 一种定量检测可溶性生长刺激表达蛋白2的试验装置 |
| PL228091B1 (pl) * | 2014-02-12 | 2018-02-28 | Inst Biochemii I Biofizyki Polskiej Akademii Nauk | Zestaw biomarkerów transkryptomicznych do zastosowania w stratyfikacji indywidualnego ryzyka rozwoju pozawałowej niewydolnosci serca, sposób diagnozowania ryzyka wystapienia u pacjenta pozawałowej niewydolnosci serca i zastosowanie biomarkerów do diagnostyki in vitro |
| US10041120B2 (en) | 2014-05-28 | 2018-08-07 | Scripps Health | Predictive analysis for myocardial infarction |
| CN105243294B (zh) * | 2015-09-18 | 2017-06-09 | 淮南师范学院 | 一种用于预测癌症病人预后相关的蛋白质对的方法 |
| RU2634375C2 (ru) * | 2016-04-18 | 2017-10-26 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт кардиологии" | Способ предупреждения постинфарктного ремоделирования сердца в эксперименте |
| ES2967443T3 (es) * | 2016-07-06 | 2024-04-30 | Guardant Health Inc | Procedimientos de perfilado de fragmentoma de ácidos nucleicos sin células |
| DE102017116204B4 (de) * | 2017-07-18 | 2024-06-27 | Universität Rostock | Verfahren zur Vorhersage der Antwort auf die kardiovaskuläre Regeneration |
| US11708600B2 (en) * | 2017-10-05 | 2023-07-25 | Decode Health, Inc. | Long non-coding RNA gene expression signatures in disease diagnosis |
| CN114449944A (zh) * | 2019-09-30 | 2022-05-06 | 豪夫迈·罗氏有限公司 | 疾病状态预测 |
| JP7489059B2 (ja) * | 2020-04-21 | 2024-05-23 | 国立大学法人横浜国立大学 | 画像生成装置、表示装置、画像生成方法、提示方法およびプログラム |
| US11915807B1 (en) * | 2022-10-11 | 2024-02-27 | Flatiron Health, Inc. | Machine learning extraction of clinical variable values for subjects from clinical record data |
| US11854675B1 (en) | 2022-10-11 | 2023-12-26 | Flatiron Health, Inc. | Machine learning extraction of clinical variable values for subjects from clinical record data |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000052462A1 (en) * | 1999-03-03 | 2000-09-08 | Ludwig Institute For Cancer Research | Heart abnormalities in vascular endothelial growth factor b (vegf-b) deficient animals and methods relating to these heart abnormalities |
| CN1139811C (zh) * | 1999-11-09 | 2004-02-25 | 赵永同 | 肿瘤早期检测评估试剂盒及其制备工艺 |
| CN1260492A (zh) * | 1999-11-09 | 2000-07-19 | 赵永同 | 肿瘤预后评估试剂盒及其制备工艺 |
| CN100399030C (zh) * | 1999-11-16 | 2008-07-02 | 杰南技术公司 | 用于vegf的elisa |
| CA2409948A1 (en) * | 2000-05-17 | 2001-11-22 | Xuri Li | Methods for detecting for the presence of tumor cells and for screening for anti-tumor agents |
| NZ529915A (en) * | 2001-06-20 | 2007-07-27 | Ludwig Inst Cancer Res | Stimulation of vascularization of ischemic tissue by angiogenesis with VEGF-B186 |
| AU2002356033A1 (en) * | 2001-08-13 | 2003-03-03 | Genetics Development Corporation | A molecular diagnostic and computerized decision support system for selecting the optimum treatment for human cancer |
| US20030096248A1 (en) * | 2001-09-04 | 2003-05-22 | Vitivity, Inc. | Diagnosis and treatment of vascular disease |
| US7435419B2 (en) * | 2002-07-19 | 2008-10-14 | Beth Israel Deaconess Medical Center | Methods of diagnosing and treating pre-eclampsia or eclampsia |
| CA2509063C (en) * | 2002-11-16 | 2010-11-02 | Dade Behring Marburg Gmbh | Scd40l and placental growth factor (plgf) as biochemical marker combinations in cardiovascular diseases |
| WO2005054860A1 (en) * | 2003-12-01 | 2005-06-16 | Dako Denmark A/S | Methods and compositions for immuno-histochemical detection |
| WO2006001888A2 (en) * | 2004-04-16 | 2006-01-05 | Acuity Pharmaceuticals Inc | Compositions and methods for inhibiting angiogenesis |
| US20070037232A1 (en) * | 2005-03-31 | 2007-02-15 | Barasch Jonathan M | Detection of NGAL in chronic renal disease |
| TW200732347A (en) * | 2005-10-06 | 2007-09-01 | Trophogen Inc | VEGF analogs and methods of use |
-
2009
- 2009-10-30 CN CN200980143296XA patent/CN102203606A/zh active Pending
- 2009-10-30 US US12/998,543 patent/US20110294683A1/en not_active Abandoned
- 2009-10-30 EP EP09752320.3A patent/EP2362942B1/en not_active Not-in-force
- 2009-10-30 ES ES09752320.3T patent/ES2640900T3/es active Active
- 2009-10-30 BR BRPI0920069A patent/BRPI0920069A8/pt not_active IP Right Cessation
- 2009-10-30 WO PCT/EP2009/064410 patent/WO2010049538A1/en not_active Ceased
- 2009-10-30 RU RU2011121613/15A patent/RU2545757C2/ru active
- 2009-10-30 CA CA2741117A patent/CA2741117A1/en not_active Abandoned
- 2009-10-30 JP JP2011533750A patent/JP5749171B2/ja not_active Expired - Fee Related
-
2015
- 2015-09-22 US US14/861,506 patent/US20160188835A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| RU2011121613A (ru) | 2012-12-10 |
| ES2640900T3 (es) | 2017-11-07 |
| JP5749171B2 (ja) | 2015-07-15 |
| EP2362942B1 (en) | 2017-06-21 |
| RU2545757C2 (ru) | 2015-04-10 |
| JP2012507026A (ja) | 2012-03-22 |
| EP2362942A1 (en) | 2011-09-07 |
| CN102203606A (zh) | 2011-09-28 |
| US20110294683A1 (en) | 2011-12-01 |
| CA2741117A1 (en) | 2010-05-06 |
| BRPI0920069A8 (pt) | 2017-10-03 |
| US20160188835A1 (en) | 2016-06-30 |
| WO2010049538A1 (en) | 2010-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FIC20250022I1 (fi) | Atetsolitsumabi | |
| FIC20220024I1 (fi) | Anifrolumabi | |
| NL300965I2 (nl) | Patisiran | |
| NL300961I2 (nl) | Erenumab | |
| FIC20170031I1 (fi) | alirokumabi | |
| EP2265642A4 (en) | BIOMARKERS | |
| DK2370462T3 (da) | Glucagon-analoger | |
| DK2342317T3 (da) | Hængende-dråbe-plade | |
| BRPI0907376A2 (pt) | Fotobiorretador | |
| DK3444343T3 (da) | Polypeptider | |
| DE602008003521D1 (de) | Sitzrücklehnungsmechanismus | |
| EP2245464A4 (en) | P53 BIOMARKERS | |
| DK2379557T3 (da) | Aminopyrazol-forbindelse | |
| DK2271613T3 (da) | Hydroxymethylcyklohexylaminer | |
| EP2257170A4 (en) | TETRAHYDROFUROPYRIDONE | |
| EP2263086A4 (en) | BIOMARKERS | |
| EP2339366A4 (en) | DEVICE FOR OPTICAL DISTANCE MEASUREMENT | |
| DE602009000862D1 (de) | Gehwagenbremse | |
| DE112009001946A5 (de) | Mobelauszugsführung | |
| BRPI0909637A2 (pt) | 2-aminoquinolinas | |
| EP2265641A4 (en) | BIOMARKERS | |
| FI20080325A0 (fi) | Pihkaliuos | |
| DK2517018T3 (da) | Biomarkører | |
| FIU20080263U0 (fi) | Suunhoitovalmiste | |
| FI8146U1 (fi) | Luontaislämpölattia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved |
Owner name: LUXEMBOURG INSTITUTE OF HEALTH (LU) |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2486 DE 28-08-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |